S100A4 and lung carcinoma: In this study, we investigated the contribution of S100A4 in lung cancer cell invasion, determined the clinical significance of S100A4 expression in patient-derived lung cancer tissues, and provided a rational for targeting S100A4 signaling through repurposing an FDA-approved drug.